| 1 |
Bray Freddie, Ferlay Jacques, Soerjomataram Isabelle, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
| 2 |
Murakami Shuji, Ito Hiroyuki, Tsubokawa Norifumi, et al. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma[J]. Lung Cancer, 2015, 90(2): 199-204.
|
| 3 |
中华医学会呼吸病学分会肺癌学组，中国肺癌防治联盟专家组. 肺部结节诊治中国专家共识 [J]. 中华结核和呼吸杂志，2015, 38(4): 249-255.
|
| 4 |
National Lung Screening Trial Research Team, Aberle Denise R, Adams Amanda M, et al. National lung screening trial research team. reduced lung-cancer mortality with low-dose computed tomographic screening[J]. N Engl J Med, 2011, 365(5): 395-409.
|
| 5 |
Field JK, , Duffy SW, Baldwin DR, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening[J]. Thorax, 2016, 71(2): 161-70.
|
| 6 |
van Klaveren Rob J, Oudkerk Matthijs, Prokop Mathias, et al. Management of lung nodules detected by volume CT scanning[J]. N Engl J Med, 2009, 361(23): 2221-2229.
|
| 7 |
Zeng Hongmei, Chen Wanqing, Zheng Rongshou, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J]. Lancet Glob Health, 2018, 6(5): e555.
|
| 8 |
Oudkerk Matthijs, Liu ShiYuan, Heuvelmans Marjolein A, et al. Lung cancer LDCT screening and mortality reduction evidence, pitfalls and future perspectives[J]. Nat Rev Clin Oncol, 2021, 18(3): 135-151.
|
| 9 |
Sullivan Donald R, Golden Sara E, Ganzini Linda, et al. 'I still don’t know diddly’：a longitudinal qualitative study of patients’ knowledge and distress while undergoing evaluation of incidental pulmonary nodules[J]. NPJ Prim Care Respir Med, 2015, 25: 15028.
|
| 10 |
刘 丹，黄 燕，周清华，等. 肺结节/肺癌患者全程管理模式的设计与应用[J]. 中国肺癌杂志，2020, 23(5): 299-305.
|
| 11 |
Ye Xin, Fan Weijun, Wang Hui, et al. Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition)[J]. J Cancer Res Ther, 2018, 14(4): 730-744.
|
| 12 |
Zhao Ze-Rui, Situ Dong-Rong, Lau Rainbow WH, et al. Comparison of segmentectomy and lobectomy in stage IA adenocarcinomas[J]. J Thorac Oncol, 2017, 12(5): 890-896.
|
| 13 |
Hong Qun-Ying, Wu Guo-Ming, Qian Gui-Sheng, et al. Prevention and management of lung cancer in China[J]. Cancer, 2015, 121(Suppl 17): 3080-3088.
|
| 14 |
Shi Ju-Fang, Wang Le, Wu Ning, et al. Clinical characteristics and medical service utilization of lung cancer in China, 2005-2014: Overall design and results from a multicenter retrospective epidemiologic survey[J]. Lung Cancer, 2019, 128: 91-100.
|
| 15 |
Leung Clarus, Shaipanich Tawimas. Current practice in the management of pulmonary nodules detected on computed tomography chest scans[J]. Can Respir J, 2019, 2019: 9719067.
|
| 16 |
Stokes Sean M, Massarweh Nader N, Stringham John R, et al. Clinical-pathologic correlation and guideline concordance in resectable non-small cell lung cancer[J]. Ann Thorac Surg, 2019, 108(3): 837-844.
|
| 17 |
Kerpel-Fronius Anna, Tammemägi Martin, Cavic Milena, et al. Screening for lung cancer in individuals who never smoked: an international association for the study of lung cancer early detection and screening committee report[J]. J Thorac Oncol, 2022, 17(1): 56-66.
|
| 18 |
Network, N．C.C., NCCN clinical practice guidelines in oncology (NCCN Guidelines) lung cancer screening version 1.2021. 2021.
|
| 19 |
US Preventive Services Task Force, Krist Alex H, Davidson Karina W，et al. Screening for lung cancer: US preventive services task force recommendation statement[J]. Jama, 2021, 325(10): 962-969.
|
| 20 |
Bai Chunxue, Choi Chang-Min, Chu Chung Ming, et al. Evaluation of pulmonary nodules: clinical practice consensus guidelines for asia[J]. Chest, 2016, 150(4): 877-893.
|